New Alzheimer's drug 'opens door for more funding'

UK Dementia Research Institute Programme's Professor Tara Spires-Jones says the research breakthrough in the treatment of Alzheimer's will hopefully 'bring more investment'.

Lecanemab is the first drug to slow the destruction of the brain in Alzheimer's.